EMR200061-005: Phase III Pergoveris in ART

• Research type

  Research Study

• Full title

  A phase III, randomized, controlled, single-blind, multicentre, parallel arm trial to assess the efficacy and safety of Pergoveris® (follitropin alfa and lutropin alfa) and GONAL-f® (follitropin alfa) for multifollicular development as part of an assisted reproductive technology treatment cycle in poor ovarian responders, as defined by the European Society of Human Reproduction and Embryology criteria

• IRAS ID

  141523

• Contact name

  Professor Roy Homburg

• Contact email

  roy.homburg@homerton.nhs.uk

• Sponsor organisation

  Merck KGaA Darmstadt

• Eudract number

  2013-003817-16

• ISRCTN Number

  N/A

• REC name

  London - South East Research Ethics Committee

• REC reference

  13/LO/1814

• Date of REC Opinion

  30 Jan 2014

• REC opinion

  Further Information Favourable Opinion